rs3026782

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020975.6(RET):​c.*388G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.182 in 382,804 control chromosomes in the GnomAD database, including 7,103 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2507 hom., cov: 31)
Exomes 𝑓: 0.19 ( 4596 hom. )

Consequence

RET
NM_020975.6 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.18

Publications

12 publications found
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
RET Gene-Disease associations (from GenCC):
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • multiple endocrine neoplasia type 2A
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
  • multiple endocrine neoplasia type 2B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Hirschsprung disease, susceptibility to, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Haddad syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • bilateral renal agenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 10-43128657-G-A is Benign according to our data. Variant chr10-43128657-G-A is described in ClinVar as Benign. ClinVar VariationId is 299908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.242 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020975.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
NM_020975.6
MANE Select
c.*388G>A
3_prime_UTR
Exon 20 of 20NP_066124.1
RET
NM_001406759.1
c.*388G>A
3_prime_UTR
Exon 20 of 20NP_001393688.1
RET
NM_020630.7
c.*1903G>A
3_prime_UTR
Exon 19 of 19NP_065681.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
ENST00000355710.8
TSL:5 MANE Select
c.*388G>A
3_prime_UTR
Exon 20 of 20ENSP00000347942.3
RET
ENST00000683007.1
n.4696G>A
non_coding_transcript_exon
Exon 16 of 16
RET
ENST00000615310.5
TSL:5
c.*1903G>A
3_prime_UTR
Exon 17 of 17ENSP00000480088.2

Frequencies

GnomAD3 genomes
AF:
0.173
AC:
26238
AN:
151526
Hom.:
2509
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.111
Gnomad AMI
AF:
0.166
Gnomad AMR
AF:
0.248
Gnomad ASJ
AF:
0.202
Gnomad EAS
AF:
0.110
Gnomad SAS
AF:
0.236
Gnomad FIN
AF:
0.233
Gnomad MID
AF:
0.247
Gnomad NFE
AF:
0.183
Gnomad OTH
AF:
0.184
GnomAD4 exome
AF:
0.188
AC:
43384
AN:
231160
Hom.:
4596
Cov.:
0
AF XY:
0.192
AC XY:
22728
AN XY:
118322
show subpopulations
African (AFR)
AF:
0.113
AC:
965
AN:
8564
American (AMR)
AF:
0.298
AC:
2600
AN:
8728
Ashkenazi Jewish (ASJ)
AF:
0.202
AC:
1745
AN:
8654
East Asian (EAS)
AF:
0.104
AC:
1866
AN:
17974
South Asian (SAS)
AF:
0.248
AC:
6832
AN:
27570
European-Finnish (FIN)
AF:
0.208
AC:
1565
AN:
7538
Middle Eastern (MID)
AF:
0.247
AC:
255
AN:
1032
European-Non Finnish (NFE)
AF:
0.182
AC:
24907
AN:
136836
Other (OTH)
AF:
0.186
AC:
2649
AN:
14264
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1770
3539
5309
7078
8848
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.173
AC:
26245
AN:
151644
Hom.:
2507
Cov.:
31
AF XY:
0.176
AC XY:
13055
AN XY:
74034
show subpopulations
African (AFR)
AF:
0.111
AC:
4577
AN:
41312
American (AMR)
AF:
0.248
AC:
3782
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.202
AC:
703
AN:
3472
East Asian (EAS)
AF:
0.110
AC:
565
AN:
5142
South Asian (SAS)
AF:
0.236
AC:
1134
AN:
4800
European-Finnish (FIN)
AF:
0.233
AC:
2435
AN:
10456
Middle Eastern (MID)
AF:
0.231
AC:
68
AN:
294
European-Non Finnish (NFE)
AF:
0.183
AC:
12449
AN:
67924
Other (OTH)
AF:
0.181
AC:
381
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1083
2167
3250
4334
5417
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
278
556
834
1112
1390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.190
Hom.:
876
Bravo
AF:
0.173
Asia WGS
AF:
0.168
AC:
584
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hirschsprung disease, susceptibility to, 1 (1)
-
-
1
Multiple endocrine neoplasia (1)
-
-
1
not provided (1)
-
-
1
Pheochromocytoma (1)
-
-
1
Renal hypodysplasia/aplasia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.30
DANN
Benign
0.69
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3026782; hg19: chr10-43624105; COSMIC: COSV60686309; COSMIC: COSV60686309; API